• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的发病与预防。

The initiation and prevention of multiple sclerosis.

机构信息

Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.

出版信息

Nat Rev Neurol. 2012 Nov 5;8(11):602-12. doi: 10.1038/nrneurol.2012.198. Epub 2012 Oct 9.

DOI:10.1038/nrneurol.2012.198
PMID:23045241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4467212/
Abstract

Although strong genetic determinants of multiple sclerosis (MS) exist, the findings of migration studies support a role for environmental factors in this disease. Through rigorous epidemiological investigation, Epstein-Barr virus infection, vitamin D nutrition and cigarette smoking have been identified as likely causal factors in MS. In this Review, the strength of this evidence is discussed, as well as the potential biological mechanisms underlying the associations between MS and environmental, lifestyle and dietary factors. Both vitamin D nutrition and cigarette smoking are modifiable; as such, increasing vitamin D levels and smoking avoidance have the potential to substantially reduce MS risk and influence disease progression. Improving our understanding of the environmental factors involved in MS will lead to new and more-effective approaches to prevent this disease.

摘要

尽管多发性硬化症(MS)存在强烈的遗传决定因素,但迁移研究的结果支持环境因素在这种疾病中的作用。通过严格的流行病学调查,已确定 Epstein-Barr 病毒感染、维生素 D 营养和吸烟是 MS 的可能因果因素。在这篇综述中,讨论了这一证据的强度,以及 MS 与环境、生活方式和饮食因素之间关联的潜在生物学机制。维生素 D 营养和吸烟都是可以改变的;因此,提高维生素 D 水平和避免吸烟有可能显著降低 MS 的风险并影响疾病进展。提高我们对 MS 中涉及的环境因素的理解将导致预防这种疾病的新的、更有效的方法。

相似文献

1
The initiation and prevention of multiple sclerosis.多发性硬化症的发病与预防。
Nat Rev Neurol. 2012 Nov 5;8(11):602-12. doi: 10.1038/nrneurol.2012.198. Epub 2012 Oct 9.
2
Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.多发性硬化症与环境因素:维生素D、寄生虫及爱泼斯坦-巴尔病毒感染的作用
Acta Neurol Scand. 2015;132(199):46-55. doi: 10.1111/ane.12431.
3
Vitamin D and multiple sclerosis: An update.维生素D与多发性硬化症:最新进展
Mult Scler Relat Disord. 2017 May;14:35-45. doi: 10.1016/j.msard.2017.03.014. Epub 2017 Mar 29.
4
Epidemiology of multiple sclerosis: from risk factors to prevention.多发性硬化症的流行病学:从风险因素到预防
Semin Neurol. 2008 Feb;28(1):17-28. doi: 10.1055/s-2007-1019126.
5
Environmental factors in multiple sclerosis.多发性硬化的环境因素。
Expert Rev Neurother. 2013 Dec;13(12 Suppl):3-9. doi: 10.1586/14737175.2013.865866.
6
Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein-Barr virus infection.纬度与多发性硬化症患病率:维生素D可降低感染爱泼斯坦-巴尔病毒的风险。
Mult Scler. 2010 Mar;16(3):373; author reply 374-5. doi: 10.1177/1352458509358093. Epub 2009 Dec 22.
7
Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis.维生素 D 与其他环境风险因素在哥伦比亚多发性硬化症患者中的作用
Mult Scler Relat Disord. 2020 Jun;41:101983. doi: 10.1016/j.msard.2020.101983. Epub 2020 Feb 4.
8
EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis.EBNA1、EBNA2 和 EBNA3 将 Epstein-Barr 病毒与多发性硬化症发病机制中的维生素 D 缺乏联系起来。
J Neuroimmunol. 2020 Feb 15;339:577116. doi: 10.1016/j.jneuroim.2019.577116. Epub 2019 Nov 20.
9
Disease mechanisms in MS: informing tactics to combat MS.多发性硬化症的发病机制:为对抗多发性硬化症提供策略依据。
Nat Rev Neurol. 2012 Nov 5;8(11):589. doi: 10.1038/nrneurol.2012.218.
10
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.多发性硬化症中的环境因素:爱泼斯坦-巴尔病毒、维生素D与吸烟。
Mt Sinai J Med. 2011 Mar-Apr;78(2):221-30. doi: 10.1002/msj.20240.

引用本文的文献

1
Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis.在多发性硬化症的人源化小鼠模型中,爱泼斯坦-巴尔病毒感染会促进T细胞失调。
Sci Adv. 2025 Mar 7;11(10):eadu5110. doi: 10.1126/sciadv.adu5110. Epub 2025 Mar 5.
2
Navigating Epstein-Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance.小儿肝移植中应对爱泼斯坦-巴尔病毒(EBV)和移植后淋巴细胞增生性疾病(PTLD):当前的认识以及治疗与监测策略
Viruses. 2025 Feb 13;17(2):254. doi: 10.3390/v17020254.
3
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.

本文引用的文献

1
Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children.瑞典儿童感染爱泼斯坦-巴尔病毒的年龄及爱泼斯坦-巴尔病毒核抗原-1抗体
Mult Scler Relat Disord. 2012 Jul;1(3):136-8. doi: 10.1016/j.msard.2012.03.002. Epub 2012 Mar 31.
2
Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel.美国军事人员队列研究中血清 25-羟维生素 D 水平与 1 型糖尿病风险
Am J Epidemiol. 2013 Mar 1;177(5):411-9. doi: 10.1093/aje/kws243. Epub 2013 Feb 3.
3
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
多发性硬化症的多基因性质:基因变异、免疫调节及与环境的关联
Endocr Metab Immune Disord Drug Targets. 2024 Dec 31. doi: 10.2174/0118715303325979241206115417.
4
The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.爱泼斯坦-巴尔病毒与MYC在伯基特淋巴瘤发病机制中的功能相互作用
Cancers (Basel). 2024 Dec 18;16(24):4212. doi: 10.3390/cancers16244212.
5
Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis.爱泼斯坦-巴尔病毒、维生素D与免疫反应:与多发性硬化症后果的关联
Front Immunol. 2024 Dec 23;15:1503808. doi: 10.3389/fimmu.2024.1503808. eCollection 2024.
6
Vitamin D receptor gene polymorphisms in patients with relapsing multiple sclerosis.复发型多发性硬化症患者维生素D受体基因多态性
Eur J Transl Myol. 2025 Mar 31;35(1). doi: 10.4081/ejtm.2024.12993. Epub 2024 Nov 21.
7
Global burden of multiple sclerosis and its attributable risk factors, 1990-2019.1990 - 2019年全球多发性硬化症负担及其归因风险因素
Front Neurol. 2024 Oct 25;15:1448377. doi: 10.3389/fneur.2024.1448377. eCollection 2024.
8
Nationwide Prevalence and Geographic Variation of Idiopathic Intracranial Hypertension among Women in the United States.美国女性特发性颅内高压的全国患病率及地理差异
Ophthalmology. 2025 Apr;132(4):476-483. doi: 10.1016/j.ophtha.2024.10.031. Epub 2024 Nov 6.
9
, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?神经退行性疾病与自身免疫性疾病:它们之间有什么关系?
Viruses. 2024 Jan 17;16(1):133. doi: 10.3390/v16010133.
10
Nerve Growth Factor and Autoimmune Diseases.神经生长因子与自身免疫性疾病
Curr Issues Mol Biol. 2023 Nov 10;45(11):8950-8973. doi: 10.3390/cimb45110562.
血清维生素 D 水平较低与多发性硬化症的复发风险增加有关。
Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13.
4
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.维生素 D 与多发性硬化症在干扰素-β治疗前后的疾病活动。
Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13.
5
Vitamin D in MS: a vitamin for 4 seasons.多发性硬化症中的维生素D:四季皆宜的维生素。
Neurology. 2012 Jul 17;79(3):208-10. doi: 10.1212/WNL.0b013e31825fe131. Epub 2012 Jun 13.
6
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.海湾战争时期多发性硬化队列:按种族、性别和服役分类的年龄和发病率。
Brain. 2012 Jun;135(Pt 6):1778-85. doi: 10.1093/brain/aws099.
7
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.一项针对多发性硬化症患者的随机、双盲、安慰剂对照试验,研究维生素 D3 作为干扰素 β-1b 的附加治疗。
J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22.
8
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women.20 岁之前的高身体质量指数与男性和女性多发性硬化症的风险增加有关。
Mult Scler. 2012 Sep;18(9):1334-6. doi: 10.1177/1352458512436596. Epub 2012 Feb 10.
9
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.全基因组荟萃分析确定新的多发性硬化症易感基因座。
Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609.
10
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.CYP27B1 基因中的罕见变异与多发性硬化症有关。
Ann Neurol. 2011 Dec;70(6):881-6. doi: 10.1002/ana.22678.